Objective:To investigate the effects of different plasma/red blood cell suspension ratios on prothrombin time (PT), activated partial thromboplastin time (APTT), and fibrinogen (Fb) level in patients with postpartum hemorrhage, providing evidence for rational blood transfusion in clinical practice.Methods:This study used a retrospective design. The clinical data of 128 patients with postpartum hemorrhage admitted to Jinan Central Hospital from January 2020 to December 2023 were analyzed. The patients were divided into a control group and an observation group, with 64 patients in each group, based on different transfusion protocols. The control group received transfusion therapy using a conventional plasma/red blood cell suspension ratio, while the observation group was treated with an optimized ratio scheme. The PT, APTT, and Fb levels were compared between the two groups before and after blood transfusion. The amount of bleeding, the volume of blood transfused, and the incidence of complications were recorded and compared between the two groups.Results:Before transfusion, there were no statistically significant differences in PT, APTT, or Fb levels between the two groups (all P>0.05). After transfusion, PT and APTT in the observation group were (11.53 ± 1.08) seconds and (32.00 ± 3.00) seconds, respectively, which were significantly shorter than those in the control group [(13.02 ± 1.57) seconds, (35.00 ± 4.00) seconds, t = 8.01, 6.01, both P<0.001]. Fb levels in the observation group were significantly higher than those in the control group [(2.24 ± 0.37) g/L vs. (1.83 ± 0.47) g/L, t = 5.48, P<0.001]. The amount of bleeding and the volume of red blood cell suspension transfused in the observation group were (800 ± 150) mL and (600 ± 80) mL, respectively, which were significantly lower than those in the control group [ (1 200 ± 200) mL, (800 ± 100) mL, t = 12.01, 10.01, both P<0.001]. There was no statistically significant difference in the volume of blood transfused between the two groups ( t = 0.00, P = 1.000). The incidence of complications in the observation group was significantly lower than that in the control group [10.94% (7/64) vs. 20.31% (13/64), χ2 = 4.60, P = 0.032]. Conclusions:The optimized plasma/red blood cell suspension ratio can effectively improve the coagulation function of patients with postpartum hemorrhage, reduce bleeding and transfusion-related complications.

Objective:To investigate the effects of different plasma/red blood cell suspension ratios on prothrombin time (PT), activated partial thromboplastin time (APTT), and fibrinogen (Fb) level in patients with postpartum hemorrhage, providing evidence for rational blood transfusion in clinical practice.Methods:This study used a retrospective design. The clinical data of 128 patients with postpartum hemorrhage admitted to Jinan Central Hospital from January 2020 to December 2023 were analyzed. The patients were divided into a control group and an observation group, with 64 patients in each group, based on different transfusion protocols. The control group received transfusion therapy using a conventional plasma/red blood cell suspension ratio, while the observation group was treated with an optimized ratio scheme. The PT, APTT, and Fb levels were compared between the two groups before and after blood transfusion. The amount of bleeding, the volume of blood transfused, and the incidence of complications were recorded and compared between the two groups.Results:Before transfusion, there were no statistically significant differences in PT, APTT, or Fb levels between the two groups (all P>0.05). After transfusion, PT and APTT in the observation group were (11.53 ± 1.08) seconds and (32.00 ± 3.00) seconds, respectively, which were significantly shorter than those in the control group [(13.02 ± 1.57) seconds, (35.00 ± 4.00) seconds, t = 8.01, 6.01, both P<0.001]. Fb levels in the observation group were significantly higher than those in the control group [(2.24 ± 0.37) g/L vs. (1.83 ± 0.47) g/L, t = 5.48, P<0.001]. The amount of bleeding and the volume of red blood cell suspension transfused in the observation group were (800 ± 150) mL and (600 ± 80) mL, respectively, which were significantly lower than those in the control group [ (1 200 ± 200) mL, (800 ± 100) mL, t = 12.01, 10.01, both P<0.001]. There was no statistically significant difference in the volume of blood transfused between the two groups ( t = 0.00, P = 1.000). The incidence of complications in the observation group was significantly lower than that in the control group [10.94% (7/64) vs. 20.31% (13/64), χ2 = 4.60, P = 0.032]. Conclusions:The optimized plasma/red blood cell suspension ratio can effectively improve the coagulation function of patients with postpartum hemorrhage, reduce bleeding and transfusion-related complications.

We conducted a prospective study to assess the non-inferiority of adjuvant chemotherapy alone versus adjuvant concurrent chemoradiotherapy (CCRT) as an alternative strategy for patients with early-stage (FIGO 2009 stage IB-IIA) cervical cancer having risk factors after surgery. The condition was assessed in terms of prognosis, adverse effects, and quality of life. This randomized trial involved nine centers across China. Eligible patients were randomized to receive adjuvant chemotherapy or CCRT after surgery. The primary end-point was progression-free survival (PFS). From December 2012 to December 2014, 337 patients were subjected to randomization. Final analysis included 329 patients, including 165 in the adjuvant chemotherapy group and 164 in the adjuvant CCRT group. The median follow-up was 72.1 months. The three-year PFS rates were both 91.9%, and the five-year OS was 90.6% versus 90.0% in adjuvant chemotherapy and CCRT groups, respectively. No significant differences were observed in the PFS or OS between groups. The adjusted HR for PFS was 0.854 (95% confidence interval 0.415-1.757; P = 0.667) favoring adjuvant chemotherapy, excluding the predefined non-inferiority boundary of 1.9. The chemotherapy group showed a tendency toward good quality of life. In comparison with post-operative adjuvant CCRT, adjuvant chemotherapy treatment showed non-inferior efficacy in patients with early-stage cervical cancer having pathological risk factors. Adjuvant chemotherapy alone is a favorable alternative post-operative treatment.
Female ; Humans ; Uterine Cervical Neoplasms/drug therapy* ; Prospective Studies ; Quality of Life ; Neoplasm Staging ; Chemoradiotherapy ; Chemotherapy, Adjuvant/adverse effects* ; Adjuvants, Immunologic ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use* ; Retrospective Studies